Article Text

Download PDFPDF
A1.35 Cryopreservation of human synovial tissue for biobanking purposes
  1. M de Vries,
  2. MGA Broeren,
  3. MB Bennink,
  4. van Lent Plem,
  5. PM van der Kraan,
  6. MI Koenders,
  7. FAJ van de Loo
  1. Experimental Rheumatology, Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands


Background and objectives Human synovial tissue derived from joint surgery of osteoarthritis (OA) and rheumatoid arthritis (RA) patients is valuable material for studying fundamental research questions. However, due to improved treatment options for these patients less joint replacement surgery is needed and less articular material becomes available for research. Additionally, performing a standardised comparative experiment with fresh tissue is difficult as material is scarce and infrequently available. It would be ideal to store and collect all this valuable tissue for later use. Therefore, a cryopreservation method has to be developed and importantly, the cryopreserved tissue should perform as freshly obtained material.

Materials and methods We used bovine metacarpophalangeal synovial tissue as a model. The inner layers of the joint capsule are isolated and 3 mm biopsies are taken. Human synovial tissue is derived, with informed consent, from joint surgery and also frozen as 3 mm biopsies. Cryosections are made to prove synovial origin. Bovine and human biopsies are cryopreserved by slow freezing using several cryoprotectant (CPA) solutions (Cryostor CS2 and standard freezing medium containing 10% DMSO and 10% FCS). For slow freezing a Mr. Frosty is used assuring a temperature decrease of 1°C/min. Thawing has been performed at 37°C, followed by quick removal of the CPA solution. Viability has been determined by MTT, XTT and ATP assays.

Results Histologically, the bovine synovial lining layer is comparable to normal human synovium. No differences were observed between freshly isolated and frozen synovium by HE staining on paraffin sections. Culturing cryopreserved bovine synovial tissue showed viability of up to 70% as determined by MTT, XTT and ATP assays. Furthermore, the standard CPA solution gives slightly higher viability values compared to the Cryostor medium. A first test with human RA tissue showed even higher viability, almost reaching the fresh values, as determined by the XTT assay. When comparing the viability assays, negative control values (tissue frozen-thawed several times without CPA solution) are lowest for the ATP assay indicating this assay could be most optimal for determining viability.

Conclusion The first results of the viability testing after cryopreservation are promising. However, further testing, also with additional CPA solutions is required to validate the cryopreservation method. Next to general viability, preservation of the pathologic response is important. Experiments are ongoing to determine cytokine secretion after cryopreservation and this will shed some more light on the ability to preserve and biobank human synovial tissue.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.